Analysis of radiotherapy and locoregional recurrence in RxPONDER patients

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainAn analysis of data on the use of radiation therapy in a large clinical trial of patients with HR+, HER2- breast cancer who had one to

Updated on: December 17,2023

Analysis of radiotherapy and locoregional recurrence in RxPONDER patients

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainAn analysis of data on the use of radiation therapy in a large clinical trial of patients with HR+, HER2- breast cancer who had one to

Updated on:December 17,2023

For first time in 40 years, cure for acute leukemia within reach

by Tali Aronsky,Hebrew University of JerusalemBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaAcute myeloid leukemia is one of the most aggre

Updated on: March 14,2024

For first time in 40 years, cure for acute leukemia within reach

by Tali Aronsky,Hebrew University of JerusalemBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaAcute myeloid leukemia is one of the most aggre

Updated on:March 14,2024

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in

Updated on: October 15,2023

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in

Updated on:October 15,2023

Novel drug shows promising efficacy for patients with multiple myeloma

by Jenny Owen,Emory UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDResults of an international clin

Updated on: December 18,2023

Novel drug shows promising efficacy for patients with multiple myeloma

by Jenny Owen,Emory UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDResults of an international clin

Updated on:December 18,2023

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n

Updated on: December 20,2023

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n

Updated on:December 20,2023

How stress shapes cancer’s course

Studies show psychological strain can accelerate tumors — could beta blockers slow them down?

Updated on: April 08,2025

How stress shapes cancer’s course

Studies show psychological strain can accelerate tumors — could beta blockers slow them down?

Updated on:April 08,2025

Scientists uncover a missing link between poor diet and higher cancer risk

byNational University of SingaporeGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.006A research team from the National University of Singapore (NUS) has unearthed

Updated on: April 28,2024

Scientists uncover a missing link between poor diet and higher cancer risk

byNational University of SingaporeGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.006A research team from the National University of Singapore (NUS) has unearthed

Updated on:April 28,2024

Study examines causes of death in US breast cancer survivors

byWileyCredit: CC0 Public DomainSurvival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related

Updated on: December 22,2023

Study examines causes of death in US breast cancer survivors

byWileyCredit: CC0 Public DomainSurvival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related

Updated on:December 22,2023

Intestinal microorganisms influence white blood cell levels, study finds

by Hokkaido UniversityUnder normal conditions (steady state) neutrophils regulate the gut microbiota. When the number of neutrophils drops (neutropenia), the composition of the gut microbiota cha

Updated on: April 20,2024

Intestinal microorganisms influence white blood cell levels, study finds

by Hokkaido UniversityUnder normal conditions (steady state) neutrophils regulate the gut microbiota. When the number of neutrophils drops (neutropenia), the composition of the gut microbiota cha

Updated on:April 20,2024

Change in breast density over time linked to cancer risk

by Tamara Bhandari,Washington University in St. LouisChange in Mammographic Density (MD) for the Case Breast in Case Patients and Control Participants Over Time. Credit:JAMA Oncology

Updated on: January 04,2024

Change in breast density over time linked to cancer risk

by Tamara Bhandari,Washington University in St. LouisChange in Mammographic Density (MD) for the Case Breast in Case Patients and Control Participants Over Time. Credit:JAMA Oncology

Updated on:January 04,2024

Potential new treatment for angioimmunoblastic T-cell lymphoma

byUniversity of TsukubaCredit: AI-generated imageA type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from

Updated on: December 18,2023

Potential new treatment for angioimmunoblastic T-cell lymphoma

byUniversity of TsukubaCredit: AI-generated imageA type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from

Updated on:December 18,2023

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present i

Updated on: November 19,2023

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present i

Updated on:November 19,2023